• info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) +1-214-377-1121 (US)
  • Sign In
  • Register

Pharma & HealthcareGlobal Basal Cell Carcinoma Treatment Market Insights, Forecast to 2025

  • RnM2315938
  • |
  • 8 August, 2018
  • |
  • Global
  • |
  • 95 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report studies the global market size of Basal Cell Carcinoma Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Basal Cell Carcinoma Treatment in these regions.
This research report categorizes the global Basal Cell Carcinoma Treatment market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Basal cell carcinoma has a low metastasis rate and is more benign, so it is also called basal cell epithelial tumor. Based on its greater destructiveness, it is also called invasive ulcer. Basal cell carcinoma is more common in the elderly, and it occurs in the head, face, neck and back of the hand, especially the prominent part of the face. It begins with a small nodule that is skin-to-dark-infiltrated, typically waxy, translucent nodules with high curled edges. The central part begins to rupture, with black necrotic sputum, and the central necrosis spreads to the deep tissue, showing large invasive necrosis, which can reach soft tissue and bone tissue.
Among the many treatments, surgical resection is still the most effective treatment for the complete eradication of basal cell carcinoma and avoiding tumor recurrence.
In addition to surgical resection, other methods that can be used to treat basal cell carcinoma include: radiation therapy, photodynamic therapy, scraping electrocautery, cryotherapy, topical application of drugs, etc.
In 2017, the global Basal Cell Carcinoma Treatment market size was 4520 million US$ and is forecast to 9090 million US in 2025, growing at a CAGR of 9.1% from 2018. The objectives of this study are to define, segment, and project the size of the Basal Cell Carcinoma Treatment market based on company, product type, application and key regions.

The various contributors involved in the value chain of Basal Cell Carcinoma Treatment include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Basal Cell Carcinoma Treatment include
Sun Pharmaceuticals
Valeant Pharmaceuticals International
Mylan N.V.
F. Hoffmann-La Roche Ltd
Merck & Co.

Market Size Split by Type
Surgical Excision
Electrodessication & Cutterage
Moh's Surgery
Cryosurgery
Market Size Split by Application
Hospitals
Specialty Clinics
Others

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Basal Cell Carcinoma Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Basal Cell Carcinoma Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Basal Cell Carcinoma Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Basal Cell Carcinoma Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Basal Cell Carcinoma Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Basal Cell Carcinoma Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Basal Cell Carcinoma Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Study Coverage
1.1 Basal Cell Carcinoma Treatment Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type
1.4.2 Surgical Excision
1.4.3 Electrodessication & Cutterage
1.4.4 Moh's Surgery
1.4.5 Cryosurgery
1.5 Market by Application
1.5.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Basal Cell Carcinoma Treatment Market Size
2.1.1 Global Basal Cell Carcinoma Treatment Revenue 2016-2025
2.1.2 Global Basal Cell Carcinoma Treatment Sales 2016-2025
2.2 Basal Cell Carcinoma Treatment Growth Rate by Regions
2.2.1 Global Basal Cell Carcinoma Treatment Sales by Regions
2.2.2 Global Basal Cell Carcinoma Treatment Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Basal Cell Carcinoma Treatment Sales by Manufacturers
3.1.1 Basal Cell Carcinoma Treatment Sales by Manufacturers
3.1.2 Basal Cell Carcinoma Treatment Sales Market Share by Manufacturers
3.1.3 Global Basal Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Basal Cell Carcinoma Treatment Revenue by Manufacturers
3.2.1 Basal Cell Carcinoma Treatment Revenue by Manufacturers (2016-2018)
3.2.2 Basal Cell Carcinoma Treatment Revenue Share by Manufacturers (2016-2018)
3.3 Basal Cell Carcinoma Treatment Price by Manufacturers
3.4 Basal Cell Carcinoma Treatment Manufacturing Base Distribution, Product Types
3.4.1 Basal Cell Carcinoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Basal Cell Carcinoma Treatment Product Category
3.4.3 Date of International Manufacturers Enter into Basal Cell Carcinoma Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Basal Cell Carcinoma Treatment Sales by Type
4.2 Global Basal Cell Carcinoma Treatment Revenue by Type
4.3 Basal Cell Carcinoma Treatment Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Basal Cell Carcinoma Treatment Breakdown Data by Application

6 North America
6.1 North America Basal Cell Carcinoma Treatment by Countries
6.1.1 North America Basal Cell Carcinoma Treatment Sales by Countries
6.1.2 North America Basal Cell Carcinoma Treatment Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Basal Cell Carcinoma Treatment by Type
6.3 North America Basal Cell Carcinoma Treatment by Application
6.4 North America Basal Cell Carcinoma Treatment by Company

7 Europe
7.1 Europe Basal Cell Carcinoma Treatment by Countries
7.1.1 Europe Basal Cell Carcinoma Treatment Sales by Countries
7.1.2 Europe Basal Cell Carcinoma Treatment Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Basal Cell Carcinoma Treatment by Type
7.3 Europe Basal Cell Carcinoma Treatment by Application
7.4 Europe Basal Cell Carcinoma Treatment by Company

8 Asia Pacific
8.1 Asia Pacific Basal Cell Carcinoma Treatment by Countries
8.1.1 Asia Pacific Basal Cell Carcinoma Treatment Sales by Countries
8.1.2 Asia Pacific Basal Cell Carcinoma Treatment Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Basal Cell Carcinoma Treatment by Type
8.3 Asia Pacific Basal Cell Carcinoma Treatment by Application
8.4 Asia Pacific Basal Cell Carcinoma Treatment by Company

9 Central & South America
9.1 Central & South America Basal Cell Carcinoma Treatment by Countries
9.1.1 Central & South America Basal Cell Carcinoma Treatment Sales by Countries
9.1.2 Central & South America Basal Cell Carcinoma Treatment Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Basal Cell Carcinoma Treatment by Type
9.3 Central & South America Basal Cell Carcinoma Treatment by Application
9.4 Central & South America Basal Cell Carcinoma Treatment by Company

10 Middle East and Africa
10.1 Middle East and Africa Basal Cell Carcinoma Treatment by Countries
10.1.1 Middle East and Africa Basal Cell Carcinoma Treatment Sales by Countries
10.1.2 Middle East and Africa Basal Cell Carcinoma Treatment Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Basal Cell Carcinoma Treatment by Type
10.3 Middle East and Africa Basal Cell Carcinoma Treatment by Application
10.4 Middle East and Africa Basal Cell Carcinoma Treatment by Company

11 Company Profiles
11.1 Sun Pharmaceuticals
11.1.1 Sun Pharmaceuticals Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
11.1.4 Basal Cell Carcinoma Treatment Product Description
11.1.5 Recent Development
11.2 Valeant Pharmaceuticals International
11.2.1 Valeant Pharmaceuticals International Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
11.2.4 Basal Cell Carcinoma Treatment Product Description
11.2.5 Recent Development
11.3 Mylan N.V.
11.3.1 Mylan N.V. Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
11.3.4 Basal Cell Carcinoma Treatment Product Description
11.3.5 Recent Development
11.4 F. Hoffmann-La Roche Ltd
11.4.1 F. Hoffmann-La Roche Ltd Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
11.4.4 Basal Cell Carcinoma Treatment Product Description
11.4.5 Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Basal Cell Carcinoma Treatment
11.5.4 Basal Cell Carcinoma Treatment Product Description
11.5.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Basal Cell Carcinoma Treatment Raw Material
13.1.2 Basal Cell Carcinoma Treatment Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer


captcha
Enter the code in the box:


captcha
Enter the code in the box:

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may not print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

 

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.


captcha
Enter the code in the box:



Summary:
Get latest Market Research Reports on Basal Cell Carcinoma Treatment. Industry analysis & Market Report on Basal Cell Carcinoma Treatment is a syndicated market report, published as Global Basal Cell Carcinoma Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Basal Cell Carcinoma Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,900.00
$7,800.00
2,618.85
5,237.70
3,588.78
7,177.56
472,446.00
944,892.00
258,622.26
517,244.52
Add To Cart Credit card Logo

Related Reports


Reason to Buy